Macrophage Vesicles‐Loaded NIR‐II AIEgens for Precise In Situ Fluorescence Imaging of Atherosclerosis DOI

Zhiheng Luo,

Xipeng Li,

Caifa You

и другие.

Small Methods, Год журнала: 2025, Номер unknown

Опубликована: Июнь 2, 2025

Precise diagnosis of atherosclerosis (AS) is a crucial strategy for reducing acute cardiovascular events. Herein, macrophage membrane (MM)-camouflaged biomimetic vesicle loaded with near-infrared-II (NIR-II) aggregation-induced emission luminogens (AIEgens) (P4TT@MM) proposed to achieve localized in vivo imaging atherosclerosis. The AIEgens characteristics P4TT@MM effectively compensate the fluorescence intensity decrease caused by intramolecular torsional charge transfer (TICT) effect, even foam cell-rich lesions. Benefiting from camouflage MM and its strong affinity atherosclerotic plaques, enables precise targeting lesion sites, successfully achieving high-contrast plaques carotid arteries aortas AS mice model. Compared free P4TT, NIR-II increased 140% 152% aortas, respectively. Moreover, demonstrates robust biocompatibility combined significant clinical translation potential. This study may present promising tool AS.

Язык: Английский

A pH-Responsive and Guanidinium-Rich Nanoadjuvant Efficiently Delivers STING Agonist for Cancer Immunotherapy DOI

Xiao Juan Lu,

Heming Xia, Wei Gao

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Фев. 11, 2025

As natural agonists of the stimulator interferon genes (STING), cyclic dinucleotides (CDNs) have been identified as promising immunotherapies that trigger a potent immune response against tumors. However, low stability, rapid clearance, inadequate cellular uptake, and inefficient cytosol localization heavily hinder therapeutic efficacy hydrophilic negatively charged 2′, 3′-cyclic-GMP-AMP (cGAMP). How to efficiently deliver cGAMP into endoplasmic reticulum (ER) activate STING for priming remains challenging. Here, we report pH-responsive guanidinium-rich nanoagonist (nPGSA) delivery cGAMP. Compared with free cGAMP, nPGSA achieves up 37.4-fold enhancement internalization. The pH-sensitive guanidinium-functional design facilitates quick release endosome escape, thus enabling precise ER targeting 33.9-fold amplification sensibilization. Furthermore, through modulation tumor-associated macrophage (TAM) polarization, elicits antigen-specific sustained tumor regression in melanoma- neuroblastoma-bearing mice. Our study provides strategy it offers insights function modulating microenvironment cancer immunotherapy.

Язык: Английский

Процитировано

2

NIR‐II Photoacoustic Imaging‐Guided Chemo‐Photothermal Therapy Using PA1094T Combined with Anti‐CD47 Antibody: Activating Pyroptosis against Orthotopic Glioblastoma DOI
Shiying Li, Fanchu Zeng, Qi Zhou

и другие.

Advanced Healthcare Materials, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 30, 2024

Abstract Treating glioblastoma (GBM) with single‐agent chemotherapy is often ineffective due to inefficient drug delivery and the immunosuppressive tumor microenvironment, which leads resistance. Strategies that activate programmed cell death mechanisms repolarized tumor‐associated macrophages toward an antitumoral M1‐like phenotype can help reverse microenvironment. In this study, a novel approach using NIR‐II (1000–1700 nm) photoacoustic imaging (PAI)‐guided chemo‐photothermal therapy presented. imaging, its superior tissue penetration reduced background noise, enables precise targeting. A targeted nano prodrug developed poly (lactic ‐co ‐glycolic acid) nanoparticles loaded A1094 dye temozolomide (TMZ), coupled anti‐CD47 antibody. This system employs synergistic activated by light, inducing apoptosis, pyroptosis, T‐cell activation. PAI provides rapid, point‐of‐care GBM diagnosis, highlighted effective targeting of PA1094T nanoplatform. recurrent model, combination antibody significantly enhances cancer phagocytosis effectively remodels resulting in better therapeutic outcomes compared conventional therapies. These results indicate PAI‐guided cocktail promising strategy for treating GBM, potentially addressing resistance improving treatment efficacy through enhanced immunomodulation.

Язык: Английский

Процитировано

4

A stimuli-responsive immunostimulant to activate chemo-immunotherapeutic effects by inducing DNA damage and STING activation DOI

Shuiying Zhang,

Hangyu Zhou, Yixin Liu

и другие.

Journal of Colloid and Interface Science, Год журнала: 2025, Номер 688, С. 664 - 676

Опубликована: Фев. 26, 2025

Язык: Английский

Процитировано

0

Enhanced efficiency and selectivity in reactive oxygen species generation using thiazolo[5,4-d]thiazole-based supramolecular photosensitizers DOI
Guang Wang,

Tongfei Qi,

Xianjun Yin

и другие.

Science China Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Март 21, 2025

Язык: Английский

Процитировано

0

Pyrazolo[1,5-a]pyrimidine-Based Type-I Photosensitizer as an Efficient Pyroptosis Inducer for Tumor Ablation DOI
Shuo Zhang,

Jingru Qiu,

Hao Zhang

и другие.

Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Май 4, 2025

Pyroptosis is a proinflammatory and lytic programmed cell death form, which can promote cytotoxic T lymphocyte (CTL) maturation tumor infiltration through the release of damage-associated molecular patterns (DAMPs). Therefore, induction pyroptosis by small molecules promising strategy to activate antitumor immunity. In this work, we report design new class pyrazolo[1,5-a]pyrimidine-based type-I photosensitizers (PSs) as efficient inducers for cancer photodynamic therapy (PDT). Among compounds, ZS-3 exhibited most excellent reactive oxygen species (ROS) generation ability phototoxicity in vitro. It was found that induced caspase-3/gasdermin E (GSDME) pathway under light irradiation, characterized bubble formation pattern release. Furthermore, lipid nanoparticles significantly inhibited growth evoked immune responses vivo.

Язык: Английский

Процитировано

0

Homologous-Targeting Porous Type I/II Nanophotosensitizers for Efficient Delivery of STING Agonists and Enhanced Photodynamic Cancer Immunotherapy DOI
Debabrata Dutta, Xin Chen, Li Cheng

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2025, Номер unknown

Опубликована: Май 8, 2025

Immunotherapy as a transformative cancer treatment modality frequently struggles with the immunosuppressive tumor microenvironment, which hinders effective immune responses. In this report, we construct biomimetic cell membrane-cloaked porous covalent organic framework (COF) nanophotosensitizers (CMSCOFs) to synergistically enhance photodynamic therapy (PDT) and stimulate interferon genes (STING)-mediated immunotherapy. CMSCOF is prepared from porphyrin benzothiadiazole-based units cloaked 4T1 membranes for homologous targeting. The structure of COF enables efficient encapsulation non-nucleotide STING agonist SR717. Upon 660 nm light irradiation, CMSCOFs trigger both type I II effects by producing superoxide (O2•-) singlet oxygen (1O2). design improves stability mimics natural cells enhanced blood circulation, accumulation, homologous-targeting tumors. Inside tissues, unique leads immunogenic death (ICD) upon exposure irradiation. Furthermore, encapsulated SR717 released after cellular internalization activate pathway elicit potent antitumor response. This synergistic approach effectively reverses enhances cytotoxic T infiltration, suppresses primary metastatic tumors, demonstrating potential promising platform

Язык: Английский

Процитировано

0

Tumor hypoxia shapes natural killer cell anticancer activities DOI
Mauricio A. Retamal, Flavio Salazar‐Onfray, Fermín E. González

и другие.

Journal of Molecular Medicine, Год журнала: 2025, Номер unknown

Опубликована: Май 30, 2025

Язык: Английский

Процитировано

0

Macrophage Vesicles‐Loaded NIR‐II AIEgens for Precise In Situ Fluorescence Imaging of Atherosclerosis DOI

Zhiheng Luo,

Xipeng Li,

Caifa You

и другие.

Small Methods, Год журнала: 2025, Номер unknown

Опубликована: Июнь 2, 2025

Precise diagnosis of atherosclerosis (AS) is a crucial strategy for reducing acute cardiovascular events. Herein, macrophage membrane (MM)-camouflaged biomimetic vesicle loaded with near-infrared-II (NIR-II) aggregation-induced emission luminogens (AIEgens) (P4TT@MM) proposed to achieve localized in vivo imaging atherosclerosis. The AIEgens characteristics P4TT@MM effectively compensate the fluorescence intensity decrease caused by intramolecular torsional charge transfer (TICT) effect, even foam cell-rich lesions. Benefiting from camouflage MM and its strong affinity atherosclerotic plaques, enables precise targeting lesion sites, successfully achieving high-contrast plaques carotid arteries aortas AS mice model. Compared free P4TT, NIR-II increased 140% 152% aortas, respectively. Moreover, demonstrates robust biocompatibility combined significant clinical translation potential. This study may present promising tool AS.

Язык: Английский

Процитировано

0